Skip to search boxSkip to navigationSkip to main content

Structural basis of p21(H-ras) molecular switch inhibition by a neutralizing antibody

  • CRC Department of Medical Oncology
    ,
  • University College Dublin
Research Output: Contribution to journal Article Peer-review

Sustainable Development Goals

  • SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well

Abstract

The ras oncogene product p21 functions as a molecular switch in the early section of the signal transduction pathway that is involved in cell growth and differentiation. When the protein is in its GTP-complexed form it is active in signal transduction, whereas it is inactive in its GDP-complexed form. The transforming activity of p21(ras) is neutralized by the mouse monoclonal antibody Y13-259, possibly by preventing GDP-GTP exchange. A molecular model of the variable fragment of Y13-259 has been derived using a knowledge-based prediction approach and computer-assisted modeling techniques. An analysis of this model while complexed with p21(ras)/(GDP) indicated that the two molecular switch regions are constrained by complex formation. Antibody binding inhibits GDP-GTP exchange through a mechanism of steric hindrance. Having identified necessary bound sites for inhibition, and explored their electrostatic properties,it should be possible to proceed with the design of antibody mimics as therapeutic agents in cancer control.

Publication Information

Output type

Research Output: Contribution to journal Article Peer-review

Original language

English

Pages from-to (Number of pages)

Pages 42-50 (9 pages)

Journal (Volume, Issue Number)

Journal of Molecular Graphics (Volume 14, Issue 1)

Publication milestones

  • Published - 19/01/1996

Publication status

Published - 19/01/1996

ISSN

0263-7855

External Publication IDs

  • Scopus: 0029940866
  • PubMed: 8744572